13 March 2020

The Health Policy Partnership has presented a poster on radioligand therapy at the European Neuroendocrine Tumor Society (ENETS) conference, which took place online on 11­­–13 March.

The poster focuses on barriers to access to radioligand therapy in neuroendocrine cancers. Co-authored by members of the project’s multi-stakeholder steering committee, it explores the barriers to implementation of radioligand therapy specific to this rare type of cancer, and details the policy recommendations to address these barriers outlined in the report Radioligand therapy: realising the potential of targeted cancer care.

The poster has been made available online via the ENETS members’ portal and as part of the supplementary material for the journal Neuroendocrinology (p.266).